Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (41-50 of 367) with videos related to

Pageof 37
Sort By:
Wiener Klinische Wochenschrift|December 25, 2007
[Austrian Guidelines for Prophylaxis of Venous Thromboembolism]Ingrid Pabinger, Sabine Eichinger, Erich Minar, et al.
Research and Practice in Thrombosis and Haemostasis|May 24, 2021
Fibrinolysis and bleeding of unknown causeDino Mehic, Ingrid Pabinger, Cihan Ay, et al.
European Journal of Anaesthesiology|November 8, 2017
European guidelines on perioperative venous thromboembolism prophylaxis: AspirinJean-Yves Jenny, Ingrid Pabinger, Charles Marc Samama, et al.
Research and Practice in Thrombosis and Haemostasis|January 29, 2025
Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignanciesNikola Vladic, Cornelia Englisch, Cihan Ay, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 10, 2021
Natural anticoagulants: A missing link in mild to moderate bleeding tendenciesDino Mehic, Meaghan Colling, Ingrid Pabinger, et al.
Cancers|August 26, 2023
Plasma Clot Properties in Patients with Pancreatic CancerJohannes Thaler, Gerald Prager, Ingrid Pabinger, et al.
Annals of Hematology|September 16, 2010
Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debateRoberto Stasi, Adrian Newland, Patrick Thornton, et al.
Thrombosis and Haemostasis|February 8, 2013
Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopeniaJohanna Haselboeck, Alexandra Kaider, Ingrid Pabinger, et al.
Seminars in Thrombosis and Hemostasis|March 12, 2014
Immune-mediated disorders causing bleeding or thrombosis in lymphoproliferative diseasesKlaus Lechner, Ingrid Pabinger, Hanna Lena Obermeier, et al.
Thrombosis Research|January 21, 2014
Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemiaJohannes Thaler, Ingrid Pabinger, Wolfgang R Sperr, et al.
Pageof 37

Showing results (41-50 of 367) with videos related to

Sort By:
Pageof 37
Wiener Klinische Wochenschrift|December 25, 2007
[Austrian Guidelines for Prophylaxis of Venous Thromboembolism]Ingrid Pabinger, Sabine Eichinger, Erich Minar, et al.
Research and Practice in Thrombosis and Haemostasis|May 24, 2021
Fibrinolysis and bleeding of unknown causeDino Mehic, Ingrid Pabinger, Cihan Ay, et al.
European Journal of Anaesthesiology|November 8, 2017
European guidelines on perioperative venous thromboembolism prophylaxis: AspirinJean-Yves Jenny, Ingrid Pabinger, Charles Marc Samama, et al.
Research and Practice in Thrombosis and Haemostasis|January 29, 2025
Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignanciesNikola Vladic, Cornelia Englisch, Cihan Ay, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 10, 2021
Natural anticoagulants: A missing link in mild to moderate bleeding tendenciesDino Mehic, Meaghan Colling, Ingrid Pabinger, et al.
Cancers|August 26, 2023
Plasma Clot Properties in Patients with Pancreatic CancerJohannes Thaler, Gerald Prager, Ingrid Pabinger, et al.
Annals of Hematology|September 16, 2010
Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debateRoberto Stasi, Adrian Newland, Patrick Thornton, et al.
Thrombosis and Haemostasis|February 8, 2013
Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopeniaJohanna Haselboeck, Alexandra Kaider, Ingrid Pabinger, et al.
Seminars in Thrombosis and Hemostasis|March 12, 2014
Immune-mediated disorders causing bleeding or thrombosis in lymphoproliferative diseasesKlaus Lechner, Ingrid Pabinger, Hanna Lena Obermeier, et al.
Thrombosis Research|January 21, 2014
Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemiaJohannes Thaler, Ingrid Pabinger, Wolfgang R Sperr, et al.
Pageof 37